Log in to search using one of your social media accounts:

 

Asthma Drug Tied to Nightmares, Depression
But experts stress Singulair also has lifesaving benefits (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 21, 2017 Category: Psychiatry Tags: Pediatrics, Pharmacy, Psychiatry, Asthma, Allergy, News, Source Type: news

Asthma Drug Tied to Nightmares, Depression
But experts stress Singulair also has lifesaving benefits (Source: WebMD Health)
Source: WebMD Health - September 21, 2017 Category: Consumer Health News Source Type: news

Asthma Drug, Montelukast, Tied to Nightmares, Depression
THURSDAY, Sept. 21, 2017 -- The asthma medication Singulair (montelukast) appears linked to neuropsychiatric side effects, such as depression, aggression, nightmares and headaches, according to a new review by Dutch researchers. But experts aren't... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 21, 2017 Category: General Medicine Source Type: news

Adverse events are rare after single-dose montelukast exposures in children - Arnold DH, Bowman N, Reiss TF, Hartert TV, Seger DL.
STUDY OBJECTIVE: Montelukast sodium is a leukotriene-receptor antagonist approved as a controller medication for chronic asthma and allergic rhinitis in children and adults. We sought to characterize adverse events associated with single montelukast exposu... (Source: SafetyLit)
Source: SafetyLit - June 26, 2017 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Montelukast Sodium Oral Granules (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - March 23, 2017 Category: Drugs & Pharmacology Source Type: news

These 50 Washington doctors received the biggest payments from drug and device makers
French multi-national pharmaceutical company Sanofi-Aventis paid a doctor from Spokane more than $37,000 to travel to Athens and Paris in 2015. The same year, Gardasil and Singulair maker Merck Sharp& Dohme Corp. paid a doctor from Seattle almost $14,000 to travel to Australia. Sanofi and Merck together paid out nearly $1 million in Washington last year, and they're far from alone. Washington physicians received more than $48.6 million last year for travel and entertainment, consulting fees and… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 28, 2016 Category: Biotechnology Authors: Melissa Crowe Source Type: news

These 50 Washington doctors received the biggest payments from drug and device makers
French multi-national pharmaceutical company Sanofi-Aventis paid a doctor from Spokane more than $37,000 to travel to Athens and Paris in 2015. The same year, Gardasil and Singulair maker Merck Sharp& Dohme Corp. paid a doctor from Seattle almost $14,000 to travel to Australia. Sanofi and Merck together paid out nearly $1 million in Washington last year, and they're far from alone. Washington physicians received more than $48.6 million last year for travel and entertainment, consulting fees and… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 28, 2016 Category: Pharmaceuticals Authors: Melissa Crowe Source Type: news

Ajanta Pharma launches generic asthma treatment tablets in US
Ajanta Pharma has launched its generic Montelukast Sodium tablets used for treatment of asthma and seasonal allergies in the American market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 3, 2015 Category: Pharmaceuticals Source Type: news

Asthma drug Singulair may be a cure for Alzheimer's, claims study
Scientists at the Paracelsus Medical University in Salzburg, Austria, have discovered that the drug montelukast is able to reverse the brain's ageing process in rats. (Source: the Mail online | Health)
Source: the Mail online | Health - October 26, 2015 Category: Consumer Health News Source Type: news

Unichem gets USFDA nod for generic asthma treatment tablets
Drug firm Unichem Laboratories has received approval from the US health regulator for its Montelukast Sodium tablets used in prevention and chronic treatment of asthma. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 9, 2015 Category: Pharmaceuticals Source Type: news

Singulair Asthma Market to 2023 – Etiology, Pathophysiology, Diagnosis...
LifeScienceIndustryResearch.com adds “Singulair (Asthma) – Forecast and Market Analysis to 2023” to its store. Report provides sales forecast for Singulair for the top eight countries from 2013 to...(PRWeb September 19, 2014)Read the full story at http://www.prweb.com/releases/singulair-asthma-market/forecast-analysis-to-2023/prweb12184367.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 20, 2014 Category: Pharmaceuticals Source Type: news

Singulair Doesn't Ease Wheeze in Most Kids
(MedPage Today) -- Intermittent montelukast (Singulair) didn't alleviate wheezing in children, except possibly for those with a specific genetic mutation, a trial showed. (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - September 11, 2014 Category: Respiratory Medicine Source Type: news

FDA Panel Says No to Over-the-Counter Allergy Drug Singulair
Title: FDA Panel Says No to Over-the-Counter Allergy Drug SingulairCategory: Health NewsCreated: 5/6/2014 12:35:00 AMLast Editorial Review: 5/6/2014 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - May 6, 2014 Category: Allergy & Immunology Source Type: news

FDA Panel Says No to Over-the-Counter Allergy Drug Singulair
Title: FDA Panel Says No to Over-the-Counter Allergy Drug SingulairCategory: Health NewsCreated: 5/2/2014 7:36:00 PMLast Editorial Review: 5/5/2014 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - May 5, 2014 Category: Allergy & Immunology Source Type: news

FDA Panel Says No to Over-the-Counter Allergy Drug Singulair
Experts expressed relief at the decision, citing safety concerns (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 3, 2014 Category: Respiratory Medicine Authors: webmaster at doctorslounge.com Tags: Pharmacy, Pulmonology, Asthma, Allergy, News, Source Type: news

FDA Panel Rejects OTC Use of Montelukast (Singulair Allergy)FDA Panel Rejects OTC Use of Montelukast (Singulair Allergy)
The FDA advisory committee has recommended against use of partial expansion of montelukast for OTC use against allergic rhinitis. Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 2, 2014 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news

FDA Panel Nixes OTC Singulair
(MedPage Today) -- Montelukast (Singulair) should not be allowed over-the-counter use for hay fever and other upper respiratory allergy symptoms, an FDA advisory panel recommended Friday. (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 2, 2014 Category: Allergy & Immunology Source Type: news

New Sleep Articles Available from April
This month brings a bouquet of articles meant to address seasonal allergies, so common as spring flowers bloom. Included in this collection are both over-the-counter and prescription options, pills and sprays that can be used to treat allergic rhinitis. Explore these options, including: Allegra, Claritin, Zyrtec, Singulair, Nasacort, Veramyst, and Zetonna. In addition, learn how a backpack might help you to prevent snoring and sleep apnea that occurs when sleeping on your back. Read More: How a Backpack Might Prevent Snoring and Sleep Apnea Over-the-Counter Allegra Medication for Allergies Over-the-Counter Claritin M...
Source: About Sleep Disorders - April 28, 2014 Category: Sleep Medicine Source Type: news

Drug Combo Saves Kids' Tonsils in Mild OSA (CME/CE)
(MedPage Today) -- The anti-inflammatory asthma drug montelukast (Singulair) plus corticosteroids was an effective initial alternative to surgery for mild obstructive sleep apnea (OSA) in children, a retrospective study showed. (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - February 8, 2014 Category: Neurology Source Type: news

Merck Profit Plunges 50% as Generics Cut Into Sales
This year the company has been hurt by plunging sales for Singulair, Maxalt, Propecia and Clarinex.     (Source: NYT Health)
Source: NYT Health - July 30, 2013 Category: Consumer Health News Authors: By THE ASSOCIATED PRESS Tags: Company Reports Drugs (Pharmaceuticals) Merck & Company Inc Generic Brands and Products Source Type: news

Merck Announces Full-Year and Fourth-Quarter 2012 Financial Results
Dateline City:  WHITEHOUSE STATION, N.J. 2012 Full-Year Non-GAAP EPS of $3.82, Excluding Certain Items; GAAP EPS of $2.16; Fourth-Quarter Non-GAAP EPS of $0.83, Excluding Certain Items; GAAP EPS of $0.46 2012 Full-Year Worldwide Sales Were $47.3 Billion, a Decrease of 2 Percent, Including a 3 Percent Unfavorable Impact from Foreign Exchange; Fourth-Quarter Worldwide Sales Were $11.7 Billion, a Decline of 5 Percent, Including a 2 Percent Unfavorable Impact from Foreign Exchange Full-Year and Fourth-Quarter Double-Digit Gl...
Source: Merck.com - Corporate News - February 1, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Financial News Source Type: news